Literature DB >> 11306953

Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells.

S C Bischoff1, G Sellge, M P Manns, A Lorentz.   

Abstract

BACKGROUND: During the last years, mast cells have been recognized as a potent cellular source of multiple cytokines. However, little is known about the regulation of cytokine production by mature human mast cells derived from mucosal sites.
METHODS: Human mast cells were isolated from intestinal mucosa and cultured for 14 days in the presence of stem cell factor (SCF) alone or in combination with IL-4. Mast cells were then stimulated by IgE receptor cross-linking or bacterial infection and cytokine production was examined by RT-PCR and ELISA.
RESULTS: We found that human intestinal mast cells produce proinflammatory cytokines such as TNF-alpha, IL-1beta and IL-6 without further stimulation. Stimulation of the cells with gram-negative bacteria (Escherichia coli and others) caused an upregulation of TNF-alpha expression. Following IgE receptor cross-linking, we found additional expression of the Th2 cytokines IL-3, IL-5 and IL-13. Interestingly, mRNA for IL-3, IL-5 and IL-13 was also expressed in unstimulated mast cells provided they were cultured in the presence of SCF and IL-4. Moreover, IL-4 rendered mast cells capable of releasing IL-5 in response to bacterial challenge.
CONCLUSION: In the presence of the mast cell survival factor SCF, mature human mast cells produce predominantly proinflammatory cytokines, whereas in the presence of SCF and IL-4, mast cells produce not only proinflammatory but also Th2 cytokines. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306953     DOI: 10.1159/000053695

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  9 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 2.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

3.  Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis.

Authors:  Akemi Ozaki; Atsuki Fukushima; Kazuyo Fukata; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-04       Impact factor: 3.117

4.  Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells.

Authors:  Eun-Ju Lee; Geun-Eok Ji; Mi-Kyung Sung
Journal:  Inflamm Res       Date:  2010-04-13       Impact factor: 4.575

5.  Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.

Authors:  Oliver T Burton; Jaciel M Tamayo; Amanda J Stranks; Kyle J Koleoglou; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

Review 6.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  Mast cell growth, differentiation, and death.

Authors:  Michael F Gurish; Joshua A Boyce
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 8.  Mast cell tissue heterogeneity and specificity of immune cell recruitment.

Authors:  Peter W West; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

9.  Effects of Angelica gigas Nakai as an Anti-Inflammatory Agent in In Vitro and In Vivo Atopic Dermatitis Models.

Authors:  Seon Ok; Sa-Rang Oh; Tae-Sung Jung; Sang-Ok Jeon; Ji-Wook Jung; Deok-Seon Ryu
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-11       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.